Video Experimental Relacionado

Updated: Jul 12, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Una vacuna de polisacárido conjugado sintético contra Haemophilus influenzae tipo b

V Verez-Bencomo¹, V Fernández-Santana, Eugenio Hardy

¹Center for the Study of Synthetic Antigens, Facultad de Química, Universidad de la Habana, Ciudad Habana, Cuba, 10400. vicente@fq.uh.cu

Science (New York, N.Y.)

|July 27, 2004

Resumen

Las vacunas conjugadas sintéticas ofrecen una nueva forma de prevenir las infecciones bacterianas. Una nueva vacuna sintética contra Haemophilus influenzae tipo b (Hib) demostró niveles de anticuerpos protectores a largo plazo en ensayos clínicos, lo que demuestra que las vacunas sintéticas de carbohidratos son viables.

Área de la Ciencia:

Vacunología La vacunología.
Química sintética de la química sintética.
Inmunología Inmunología.

Sus antecedentes:

Las vacunas de glucoconjugado son cruciales para prevenir las infecciones bacterianas.
Las vacunas actuales se basan en polisacáridos extraídos de bacterias, lo que limita la escalabilidad y la consistencia.
Ninguna vacuna comercial ha utilizado antígenos de carbohidratos producidos sintéticamente.

Objetivo del estudio:

Para describir la síntesis a gran escala de un antígeno polisacárido cápsula sintético para Haemophilus influenzae tipo b (Hib).
Detallar el desarrollo farmacéutico y la evaluación clínica de esta nueva vacuna sintética conjugada de Hib.
Evaluar la viabilidad y eficacia de las vacunas sintéticas basadas en carbohidratos.

Principales métodos:

Síntesis química a gran escala del antígeno polisacárido capsular Hib.
Formulación farmacéutica y desarrollo de la vacuna conjugada.
Ensayos clínicos en Cuba para evaluar la seguridad y la inmunogenicidad de la vacuna.

Principales resultados:

La vacuna conjugada sintética Hib fue sintetizada y desarrollada con éxito.
Los ensayos clínicos demostraron títulos de anticuerpos protectores a largo plazo.
La eficacia de la vacuna sintética se comparó favorablemente con los productos con licencia existentes.

Conclusiones:

La síntesis a gran escala de antígenos de carbohidratos complejos para vacunas es factible.
Las vacunas conjugadas sintéticas ofrecen una alternativa viable a los antígenos extraídos de bacterias.
Este enfoque proporciona una base para el desarrollo de vacunas sintéticas contra otros patógenos.

Más Videos Relacionados

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

Videos de Conceptos Relacionados

Vaccinations

Vaccinations

Vaccine Production

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Diphtheria

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...

Influenza

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...

Respiratory Syncytial Virus Disease

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...